Biotek-snakken — August 2025
-
Fra debatten:
IO Biotech's fase 3 resultater https://proinvestor.com/boards/127841/ -
Desuden er det endnu engang et bevis på at deres platform kan levere. Det betyder bla at man ikke som normalt med Biotek, kan undlade at inkludere preclinical i valueringen af Saniona.. da de viser at de kan indgå partnerskab så tidligt. De er dygtige i Saniona. Ingen tvivl om det.
-
ViroGates offentliggør sin halvårsrapport for 1. halvår 2025 https://proinvestor.com/investornyt/1353564/virogates-offentliggor-sin-halvarsrapport-for-1-halvar-2025
-
Pharma: Får toldafklaring investorerne til at vende tilbage? https://proinvestor.com/boards/127933
-
Danske Bank ser muligheder i sundhedssektoren: Hæver til "overvægt" https://proinvestor.com/investornyt/1354620/danske-bank-ser-muligheder-i-sundhedssektoren-haever-til-overvaegt
-
Pila Pharma | Live 13.30 - CEO Gustav H. Gram H1 Report Interview https://www.youtube.com/watch?v=DcwXPx3W8t4
-
Saniona offentliggør delrapport for 2025 . https://saniona.com/newsroom/single-press-release/?slug=saniona-publishes-its-interim-report-for-the-second-quarter-of-2025
-
Dansk biotekselskab runder begivenhedsrigt halvår af: EMA-godkendelse kronen på værket https://proinvestor.com/investornyt/1356418/dansk-biotekselskab-runder-begivenhedsrigt-halvar-af-ema-godkendelse-kronen-pa-vaerket
] in brain cancer patients.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind